Brain Awareness Video Contest

How Ketamine Treats Depression

  • Published4 Sep 2019
  • Author
  • Source BrainFacts/SfN

In March 2019, the U.S. Food and Drug Administration approved ketamine for the treatment of depression — the first new antidepressant medication in decades. Unlike previous generations of antidepressants, ketamine targets the neurotransmitter glutamate. And, a single dose can work in just a few hours and the effects persist for weeks.

This video won second place in the 2019 Brain Awareness Video Contest.

Content Provided By